Get started
Author

Christine M. Bestvina

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
2020 · Nicole M Kuderer, Toni K Choueiri, et al. · The Lancet · 1,726
PDF
Patient-Oncologist Cost Communication, Financial Distress, and Medication Adherence
2014 · Christine M. Bestvina, Leah L. Zullig, et al. · Journal of Oncology Practice · 258
PDF
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
2023 · Marcelo V. Negrao, Haniel A. Araujo, et al. · Cancer Discovery · 201
PDF
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
2024 · Ferdinandos Skoulidis, Haniel A. Araujo, et al. · Nature · 186
A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study
2021 · Christine M. Bestvina, Kelli B. Pointer, et al. · Journal of Thoracic Oncology · 146
Severity of COVID-19 in patients with lung cancer: evidence and challenges
2021 · Antonio Passaro, Christine Bestvina, et al. · Journal for ImmunoTherapy of Cancer · 146
PDF
Chemotherapy for Endometrial Cancer in Adjuvant and Advanced Disease Settings
2016 · Christine M. Bestvina, Gini F. Fleming · The Oncologist · 121
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer
2021 · Stanley I. Gutiontov, William Tyler Turchan, et al. · Scientific Reports · 104
PDF
Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial
2024 · Yasutoshi Kuboki, Marwan Fakih, et al. · Nature Medicine · 102
PDF
Association of STK11/LKB1 genomic alterations with lack of benefit from the addition of pembrolizumab to platinum doublet chemotherapy in non-squamous non-small cell lung cancer.
2019 · Ferdinandos Skoulidis, Kathryn Cecilia Arbour, et al. · Journal of Clinical Oncology · 102
Implementation of Advance Care Planning in Oncology: A Review of the Literature
2017 · Christine M. Bestvina, Blase N. Polite · Journal of Oncology Practice · 94
Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade
2022 · Liam F. Spurr, Carlos A. Martinez, et al. · Nature Cancer · 91
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC
2024 · Jacobi B. Hines, Robert B. Cameron, et al. · Journal of Thoracic Oncology · 88
PDF
The Implications of Out-Of-Pocket Cost of Cancer Treatment in the USA: A Critical Appraisal of the Literature
2014 · Christine M Bestvina, Leah L Zullig, et al. · Future Oncology · 73
Brief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy
2022 · Or Kalchiem-Dekel, Christina J. Falcon, et al. · Journal of Thoracic Oncology · 48
PDF
The Role of MET in Resistance to EGFR Inhibition in NSCLC: A Review of Mechanisms and Treatment Implications
2023 · Susan L. Feldt, Christine M. Bestvina · Cancers · 37
PDF
Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal
2023 · Christine M. Bestvina, Marina C. Garassino, et al. · Journal of Clinical Oncology · 31
Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy
2021 · Nicole K. Yun, Sherin J. Rouhani, et al. · Cancers · 28
PDF
Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and Immunotherapy
2022 · Mark C. Korpics, Rohan R. Katipally, et al. · International Journal of Radiation Oncology*Biology*Physics · 22
The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project
2024 · Valeria Sebri, Chiara Marzorati, et al. · Cancer Medicine · 21
PDF
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry
2022 · Jennifer G. Whisenant, Javier Baena, et al. · Journal of Thoracic Oncology · 21
Meeting an un-MET need: Targeting MET in non-small cell lung cancer
2022 · Elena Michaels, Christine M. Bestvina · Frontiers in Oncology · 20
Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies
2022 · Sherin Juliet Rouhani, Jovian Yu, et al. · Journal for ImmunoTherapy of Cancer · 19
PDF
Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer
2022 · Steven E. Schild, Xiaofei Wang, et al. · Clinical Lung Cancer · 19
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer
2024 · Christine M. Bestvina, Dexter Waters, et al. · Journal of Medical Economics · 17
PDF
Works count: 273
Citation count: 4,052
H-index: 21
I10-index: 34
Year
Topic
Type